Key result
Stagnating US ASCVD mortality underscores the critical need for a dedicated preventive cardiology subspecialty.
Why the study?
Despite being largely preventable, ASCVD remains the leading cause of morbidity and mortality worldwide, with US mortality likely to rise again.
This review emphasizes the critical need to establish and implement the discipline of preventive cardiology to address the impending rise in ASCVD mortality.
May support preventive cardiology subspecialty development; leaves open effects on reversing mortality trends.
Despite being largely preventable, atherosclerotic cardiovascular disease (ASCVD) continues to be the leading source of morbidity and mortality worldwide. While the past few decades have seen a substantial reduction in ASCVD mortality, much of this is due to significant improvements in treatment of already manifest disease, with its attendant morbidity and impact on quality of life. Moreover, evidence now suggests that ASCVD mortality in the United States has hit a nadir and is likely to start increasing again. It is now time to shift our attention from intervention to prevention. In this review, we explore the tremendous opportunity to define and implement the discipline of preventive cardiology.
No takes yet. Share an insight, caveat, or question.
Mahmood et al. (2021) conducted a review in Atherosclerotic cardiovascular disease. Atherosclerotic cardiovascular disease mortality in the United States is stagnating and potentially rising, underscoring the critical need to establish a dedicated preventive cardiology subspecialty.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: